These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8873217)
1. Exon and intron variants in the human tryptophan 2,3-dioxygenase gene: potential association with Tourette syndrome, substance abuse and other disorders. Comings DE; Gade R; Muhleman D; Chiu C; Wu S; To M; Spence M; Dietz G; Winn-Deen E; Rosenthal RJ; Lesieur HR; Rugle L; Sverd J; Ferry L; Johnson JP; MacMurray JP Pharmacogenetics; 1996 Aug; 6(4):307-18. PubMed ID: 8873217 [TBL] [Abstract][Full Text] [Related]
2. Blood serotonin and tryptophan in Tourette syndrome. Comings DE Am J Med Genet; 1990 Aug; 36(4):418-30. PubMed ID: 2389798 [TBL] [Abstract][Full Text] [Related]
3. Serotonin and the biochemical genetics of alcoholism: lessons from studies of attention deficit hyperactivity disorder (ADHD) and Tourette syndrome. Comings DE Alcohol Alcohol Suppl; 1993; 2():237-41. PubMed ID: 7748306 [TBL] [Abstract][Full Text] [Related]
4. Hypothesis: homozygosity in Tourette syndrome. Comings DE; Comings BG; Knell E Am J Med Genet; 1989 Nov; 34(3):413-21. PubMed ID: 2596529 [TBL] [Abstract][Full Text] [Related]
5. Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. Comings DE; Muhleman D; Dietz G; Sherman M; Forest GL Genomics; 1995 Sep; 29(2):390-6. PubMed ID: 8666386 [TBL] [Abstract][Full Text] [Related]
6. Association of tryptophan 2,3 dioxygenase gene polymorphism with autism. Nabi R; Serajee FJ; Chugani DC; Zhong H; Huq AH Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):63-8. PubMed ID: 14755447 [TBL] [Abstract][Full Text] [Related]
8. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Comings DE; Gonzalez N; Wu S; Gade R; Muhleman D; Saucier G; Johnson P; Verde R; Rosenthal RJ; Lesieur HR; Rugle LJ; Miller WB; MacMurray JP Am J Med Genet; 1999 Aug; 88(4):358-68. PubMed ID: 10402503 [TBL] [Abstract][Full Text] [Related]
9. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse. Comings DE Drug Alcohol Depend; 1994 Mar; 35(1):1-16. PubMed ID: 8082550 [TBL] [Abstract][Full Text] [Related]
10. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse. Comings DE Drug Alcohol Depend; 1994 Mar; 35(1):17-24. PubMed ID: 8082551 [TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic relationships between autism-pervasive developmental disorder and Tourette syndrome: a study of 19 cases. Comings DE; Comings BG Am J Med Genet; 1991 May; 39(2):180-91. PubMed ID: 2063922 [TBL] [Abstract][Full Text] [Related]
12. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function. Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Comings DE Ann N Y Acad Sci; 2001 Jun; 931():50-83. PubMed ID: 11462757 [TBL] [Abstract][Full Text] [Related]
14. Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Rippel CA; Kobets AJ; Yoon DY; Williams PN; Shugart YY; Bridges DD; Vandenbergh DJ; Singer HS Psychiatr Genet; 2006 Oct; 16(5):179-80. PubMed ID: 16969268 [TBL] [Abstract][Full Text] [Related]
15. Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior. Brett PM; Curtis D; Robertson MM; Gurling HM Am J Psychiatry; 1995 Mar; 152(3):437-40. PubMed ID: 7864272 [TBL] [Abstract][Full Text] [Related]
16. Characterization of functional polymorphisms and glucocorticoid-responsive elements in the promoter of TDO2, a candidate gene for ethanol-induced behavioural disorders. Soichot M; Vaast A; Vignau J; Guillemin GJ; Lhermitte M; Broly F; Allorge D Alcohol Alcohol; 2013; 48(4):415-25. PubMed ID: 23558111 [TBL] [Abstract][Full Text] [Related]
17. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. Hirschtritt ME; Lee PC; Pauls DL; Dion Y; Grados MA; Illmann C; King RA; Sandor P; McMahon WM; Lyon GJ; Cath DC; Kurlan R; Robertson MM; Osiecki L; Scharf JM; Mathews CA; JAMA Psychiatry; 2015 Apr; 72(4):325-33. PubMed ID: 25671412 [TBL] [Abstract][Full Text] [Related]
18. Association of intronic variants of the BTBD9 gene with Tourette syndrome. Rivière JB; Xiong L; Levchenko A; St-Onge J; Gaspar C; Dion Y; Lespérance P; Tellier G; Richer F; Chouinard S; Rouleau GA; Arch Neurol; 2009 Oct; 66(10):1267-72. PubMed ID: 19822783 [TBL] [Abstract][Full Text] [Related]
19. Point mutations within 663-666 bp of intron 6 of the human TDO2 gene, associated with a number of psychiatric disorders, damage the YY-1 transcription factor binding site. Vasiliev GV; Merkulov VM; Kobzev VF; Merkulova TI; Ponomarenko MP; Kolchanov NA FEBS Lett; 1999 Nov; 462(1-2):85-8. PubMed ID: 10580097 [TBL] [Abstract][Full Text] [Related]
20. GDNF gene is associated with tourette syndrome in a family study. Huertas-Fernández I; Gómez-Garre P; Madruga-Garrido M; Bernal-Bernal I; Bonilla-Toribio M; Martín-Rodríguez JF; Cáceres-Redondo MT; Vargas-González L; Carrillo F; Pascual A; Tischfield JA; King RA; Heiman GA; Mir P Mov Disord; 2015 Jul; 30(8):1115-20. PubMed ID: 26096985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]